Overview

Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the tolerability and safety of Kiddi® Pharmaton Fizz effervescent tablets, in children of 6 to 14 years, comparing a given formula with an improved one with reduced mineral content (qualitatively equivalent to the first one) and a comparator product.
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim